cGMP growth factors, culture media, recombinant and human proteins, novel cryopreservation media, delivery technologies and bioengineered scaffolds for discovery, development, and commercialization. Their company’s unique business model emphasizes flexibility, quality, and unparalleled service—from research and development through clinical trial, market authorization, and commercial product.